Colleges across the U.S. are reporting outbreaks of COVID-19, the disease caused by the novel coronavirus, leaving experts and residents concerned about the pandemic worsening in certain areas. Dr. Farshad Marvasti, director of public health and prevention curriculum at the University of Arizona College of Medicine – Phoenix, said that "as we get into flu season, where health care resources will be strained further and people with other acute exacerbations of chronic diseases like heart attacks or strokes or other emergencies will not be able to get the care we need," surges of transmissions on college campuses are "a telltale sign that could be the starting point of a second wave."

Dr. James Galligan and his University of Arizona College of Pharmacy research team found inhibiting glyoxalase-II enzyme results in slower cell growth, which may help limit disease progression.

AstraZeneca and the University of Oxford have put their combined Phase 2 and 3 trial on standby after one United Kingdom participant reportedly developed severe neurological symptoms. The volunteer's condition and what brought it on remain unclear. University of Arizona immunologist Deepta Bhattacharya at the College of Medicine – Tucson, said such questions are the point of large human trials. "As we start to expand out the numbers into tens of thousands of people, will we start to see some rare events, and what is the risk-reward proposition once you start to see that data?"

New research is shining a light on an unusual treatment for migraine headaches: green light therapy. In a small study involving 29 migraine patients, University of Arizona Health Sciences researchers found that exposure to green light for one to two hours daily reduced headache pain by 60% and significantly reduced the frequency of migraines.

Amy Jang, a doctoral candidate at the University of Arizona College of Pharmacy, writes that amid the current pandemic, there is currently no official approved drug indicated to treat patients with coronavirus disease 2019. However, the FDA has temporarily approved certain antiviral medications and anti-inflammatory drugs to use for the emergency treatment of severe acute respiratory syndrome coronavirus 2 to potentially reduce hospitalization rates for infected patients.

Dr. Judith Gordon’s research team develops “See Me Serene” project with BIO5 Institute seed funding. Now available free via the App Store and Google Play, it aims to aid people’s mental and physical health.

Health Sciences researchers are recognized for mentoring students in the lab. Here’s a look at how one PI guides a graduate research assistant.

In general, deciding whether to take part in an activity is “not one size fits all,” said Dr. Shad Marvasti, director of public health at the University of Arizona College of Medicine-Phoenix. He said anyone who could be considered a vulnerable individual, such as someone who has a chronic disease or compromised immune system, should consider how essential it is to take part in a potentially risky activity.

New research from the University of Arizona Health Sciences found that people who suffer from migraine may benefit from green light therapy, which was shown to reduce the frequency and intensity of headaches and improve patient quality of life.

People who suffer from migraine are reducing their pain and improving their quality of life thanks to pain specialists at the University of Arizona Health Sciences and their green light research.